Brand-specific enhanced safety surveillance of GSK’s Fluarix Tetra seasonal influenza vaccine in England: 2017/2018 season

Brand-specific enhanced safety surveillance of GSK’s Fluarix Tetra seasonal influenza vaccine in England: 2017/2018 season

In compliance with the European Medicine Agency guidance to detect any potential safety concerns associated with influenza vaccination, an enhanced safety surveillance study was conducted in England during the 2017/18 influenza season. The primary objective was to estimate the incidence rates of adv...

Full description

Bibliographic Details
Main Authors: Simon de Lusignan, Silvia Damaso, Filipa Ferreira, Rachel Byford, Christopher McGee, Sameera Pathirannehelage, Vishvesh Shende, Ivelina Yonova, Alexander Schmidt, Anne Schuind, Gael Dos Santos
Format: Article
Language:English
Published: Taylor & Francis Group 2020-08-01
Series:Human Vaccines & Immunotherapeutics
Subjects:
safety management
medical records systems
adverse reactions
influenza vaccines
general practice
england
Online Access:http://dx.doi.org/10.1080/21645515.2019.1705112

Internet

http://dx.doi.org/10.1080/21645515.2019.1705112

Similar Items